Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Matrix metalloproteinase-2 (MMP-2) and chloride channel-3 (ClC-3) complex is a specialized macromolecular assembly found on the surface of various malignant cells, most notably high-grade gliomas (Lui et al., 2010, J Biol Chem). This complex integrates the proteolytic activity of MMP-2, which degrades the extracellular matrix, with the ion-transporting capability of ClC-3, which facilitates the rapid cell volume changes necessary for tumor cells to invade narrow interstitial spaces (McFerrin & Sontheimer, 2006, Neuron Glia Biol). The physical association of these two proteins is critical for the invasive phenotype of cancer cells, as it co-localizes the machinery for matrix remodeling and hydrodynamic regulation at the leading edge of the cell (Deshane et al., 2003, J Biol Chem). This complex serves as the specific target for chlorotoxin, a 36-amino acid peptide derived from scorpion venom that binds with high affinity and specificity to the MMP-2/ClC-3 assembly (Veiseh et al., 2007, Cancer Res). Upon binding, chlorotoxin triggers the internalization of the entire complex via endocytosis, thereby inhibiting the cell's ability to migrate and invade surrounding healthy tissue (Butt et al., 2015, Toxins). Therapeutic and diagnostic strategies leveraging this target include 'tumor paint' for intraoperative visualization and radiolabeled peptides for targeted radiotherapy (Cohen-Inbar & Zaaroor, 2016, J Clin Neurosci).
Ligand binding (e.g., chlorotoxin) to the complex induces the internalization of both MMP-2 and ClC-3 via endocytosis, which inhibits extracellular matrix degradation and prevents the chloride-dependent cell volume changes necessary for tumor cell migration and invasion.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Matrix metalloproteinase-2 and chloride channel-3 complex (MMP-2/ClC-3 complex).